Met Life Investment Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

$16.5 Billion
Q2 2025

A detailed history of Met Life Investment Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 23,093 shares of AMPH stock, worth $547,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,093

Previous 23,093 -0.0%

Holding current value

$547,996

Previous $669,000 20.78%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$26.24 - $38.48 $9,420 - $13,814	-359 Reduced 1.53%	23,093 $669,000
Q4 2024 Feb 13, 2025	BUY	$36.84 - $53.4 $31,129 - $45,123	845 Added 3.74%	23,452 $870,000
Q2 2024 Aug 13, 2024	BUY	$38.65 - $43.48 $119,428 - $134,353	3,090 Added 15.83%	22,607 $904,000
Q1 2024 May 14, 2024	BUY	$42.85 - $63.45 $836,303 - $1.24 Million	19,517 New	19,517 $856,000
Q2 2023 Apr 29, 2024	BUY	$35.77 - $58.38 $732,104 - $1.19 Million	20,467 New	20,467 $1.18 Million
Q1 2023 May 09, 2024	BUY	$27.99 - $37.92 $572,871 - $776,108	20,467 New	20,467 $768 Million
Q1 2022 May 10, 2024	BUY	$22.96 - $36.45 $469,922 - $746,022	20,467 New	20,467 $734,000
Q1 2022 Mar 22, 2023	BUY	$22.96 - $36.45 $198,925 - $315,802	8,664 Added 73.41%	20,467 $734,000
Q1 2022 May 12, 2022	BUY	$22.96 - $36.45 $198,925 - $315,802	8,664 Added 73.41%	20,467 $735,000
Q4 2021 Jun 21, 2023	SELL	$18.14 - $23.29 $157,164 - $201,784	-8,664 Reduced 42.33%	11,803 $274,000
Q3 2021 Jun 21, 2023	SELL	$17.83 - $21.49 $154,479 - $186,189	-8,664 Reduced 42.33%	11,803 $224,000
Q2 2021 Jun 21, 2023	SELL	$17.11 - $20.92 $148,241 - $181,250	-8,664 Reduced 42.33%	11,803 $237,000
Q1 2021 May 17, 2024	SELL	$17.21 - $20.65 $132,757 - $159,294	-7,714 Reduced 39.52%	11,803 $216,000
Q1 2021 Jun 26, 2023	SELL	$17.21 - $20.65 $149,107 - $178,911	-8,664 Reduced 42.33%	11,803 $216 Million
Q1 2021 Mar 22, 2023	SELL	$17.21 - $20.65 $110,178 - $132,201	-6,402 Reduced 35.17%	11,803 $216,000
Q1 2021 May 14, 2021	SELL	$17.21 - $20.65 $110,178 - $132,201	-6,402 Reduced 35.17%	11,803 $216,000
Q4 2020 Jun 22, 2023	SELL	$17.76 - $21.24 $40,173 - $48,044	-2,262 Reduced 11.05%	18,205 $366,000
Q3 2020 Jun 26, 2023	SELL	$17.99 - $22.22 $40,693 - $50,261	-2,262 Reduced 11.05%	18,205 $341,000
Q2 2020 May 24, 2024	SELL	$14.25 - $22.46 $18,696 - $29,467	-1,312 Reduced 6.72%	18,205 $409 Million
Q2 2020 Jun 26, 2023	SELL	$14.25 - $22.46 $32,233 - $50,804	-2,262 Reduced 11.05%	18,205 $408,000
Q1 2020 Jul 12, 2023	SELL	$12.66 - $20.08 $28,636 - $45,420	-2,262 Reduced 11.05%	18,205 $270,000
Q4 2019 Jul 12, 2023	SELL	$17.07 - $20.64 $38,612 - $46,687	-2,262 Reduced 11.05%	18,205 $351,000
Q3 2019 Jul 12, 2023	SELL	$19.12 - $22.62 $43,249 - $51,166	-2,262 Reduced 11.05%	18,205 $361,000
Q2 2019 Jul 12, 2023	SELL	$18.92 - $22.96 $42,797 - $51,935	-2,262 Reduced 11.05%	18,205 $384,000
Q1 2019 Jul 13, 2023	SELL	$19.46 - $25.28 $44,018 - $57,183	-2,262 Reduced 11.05%	18,205 $371,000
Q4 2018 Jul 13, 2023	SELL	$17.72 - $22.51 $40,082 - $50,917	-2,262 Reduced 11.05%	18,205 $362,000
Q4 2018 Mar 22, 2023	SELL	$17.72 - $22.51 $175,091 - $222,421	-9,881 Reduced 35.18%	18,205 $362,000
Q4 2018 Feb 14, 2019	SELL	$17.72 - $22.51 $175,091 - $222,421	-9,881 Reduced 35.18%	18,205 $362,000
Q3 2018 Jul 13, 2023	SELL	$15.39 - $19.38 $34,812 - $43,837	-2,262 Reduced 11.05%	18,205 $350,000
Q3 2018 Mar 22, 2023	BUY	$15.39 - $19.38 $117,256 - $147,656	7,619 Added 37.23%	28,086 $540,000
Q3 2018 Nov 14, 2018	BUY	$15.39 - $19.38 $152,068 - $191,493	9,881 Added 54.28%	28,086 $540,000
Q4 2017 Feb 15, 2018	BUY	$17.76 - $19.75 $323,320 - $359,548	18,205	18,205 $350,000

Others Institutions Holding AMPH

# of Institutions

260

Shares Held

32.9M

Call Options Held

18.3K

Put Options Held

12.6K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.16B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History